Compound Research Day: Ozempic for Sleep
At Compound, we've long been obsessed with sleep, publishing our in-depth research last year. It's among the highest impact indications and arguably the only population-scale one outside of GLP-1s. Every normal person instinctively gets it (e.g. in a poll we ran, most people said they'd pay $1k/month out of pocket for an Ozempic for Sleep). Yet until now pharma has paid almost no attention to it.
We're hosting a Research Day on sleep to bring together researchers, entrepreneurs, and investors working on its frontiers.
Speakers include:
Paul Dagum of Applied Cognition with its PII Alzheimer's asset that promotes deep sleep and glymphatic waste-clearance along with a headset for non-invasively measuring that in at-home settings
Keith Murphy of Attune Neurosciences on the application of FUS to sleep
Loren Frank of Stanford on his work teasing apart the mechanisms behind sleep's interplay with memory formation
Rahul Thapa of Stanford on his work developing a multimodal sleep foundation model for disease prediction and agentic analysis of 50TB of PSG data
Yanan Zhao of Stanford on her work discovering and validating novel circuit that drive sleep regulation
Yue Leng of UCSF on her epidemiology work studying the relationship between sleep and neurodegenerative diseases